From Yahoo Finance: 2025-05-07 11:06:00

Merck & Co., Inc. (MRK) is analyzed in a bullish thesis by Investing Intel, with shares trading at $84.71 on April 29th. The recent $3.9 billion acquisition of SpringWorks Therapeutics positions Merck for long-term growth and revenue generation, demonstrating a proactive approach to building its future product portfolio.

With 91 hedge fund portfolios holding MRK at the end of the fourth quarter, the company is not among the 30 Most Popular Stocks Among Hedge Funds. However, investors seeking AI stocks with greater potential for higher returns may find more promising options than MRK. Consider exploring our report on the cheapest AI stock for investment opportunities.

Read more: Merck & Co., Inc. (MRK): A Bull Case Theory